Back to results
Bibliographic record · Consultation and access
Revista científica

Application of sequencing, liquid biopsies and patient derived xenografts for personalized medicine in melanoma

Girotti, Maria Romina et al · American Association for Cancer Research · 2016

Open-access full text
Quick overview. Review the resource’s basic details, then access the content using the main button. This page shows only the information needed to identify, cite, and open the work.

Resource access

Open the content from the main option or choose another available source.

CONICET Digital CONICET Digital OAI-PMH
Entrar por CONICET Digital
Main access

Open-access full text

Texto completo identificado como acceso abierto.
Open text

Summary

Descripción general del contenido del recurso.

BRAF/MEK inhibitors and immunotherapies have revolutionized care for patients with advanced melanoma, improving expected median survival from 9 months to 25-30 months, but the majority of patients still die of their disease. Personalized medicine strives to individualize and improve patient care. Fil: Girotti, Maria Romina. Cancer Research Uk Manchester Institute; Reino Unido. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Instituto de Investigaciones Bioquímicas de Buenos Aires. Fundación Instituto Leloir. Instituto de Investigaciones Bioquímicas de Buenos Aires; Argentina Fil: Gremel, Gabriela. Cancer Research Uk Manchester Institute; Reino Unido

How to cite

Elegí el formato que necesitás y copiá la referencia al portapapeles.

APA 7

Girotti, M. R. E. A. (2016). Application of sequencing, liquid biopsies and patient derived xenografts for personalized medicine in melanoma. http://hdl.handle.net/11336/285388

MLA

Girotti, Maria Romina et al. "Application of sequencing, liquid biopsies and patient derived xenografts for personalized medicine in melanoma." 2016. http://hdl.handle.net/11336/285388.

Chicago

Girotti, Maria Romina et al. 2016. "Application of sequencing, liquid biopsies and patient derived xenografts for personalized medicine in melanoma.". http://hdl.handle.net/11336/285388.

Harvard

Girotti, M. R. E. A. 2016, Application of sequencing, liquid biopsies and patient derived xenografts for personalized medicine in melanoma, American Association for Cancer Research, available at: http://hdl.handle.net/11336/285388 [Accessed 5 Aug. 2026].

Share and print

Save the record, copy its permanent link, or print it as a PDF.

Export reference

You can export the record in common formats for use in a reference manager.

Resource details

Bibliographic information to help confirm that this is the correct material.

Title
Application of sequencing, liquid biopsies and patient derived xenografts for personalized medicine in melanoma
Author / contributors
Girotti, Maria Romina et al
Publisher
American Association for Cancer Research
Publication year
2016
ISSN
0008-5472
ISSN
0008-5472
Language
English

Subjects

Explore related resources through these subjects.

Copied